Registered Nurse

Yowei Therapeutics and Yowei Oncology are stealth-stage life-sciences companies working closely with CSBio to advance peptide-based clinical programs. Their work spans longevity and peptide therapeutics, clinical trials, evaluation of a 503A pharmacy model, personalized synthetic neoantigen peptide oncology programs, and supporting microbiology and laboratory capabilities. Together, they are building the clinical, pharmacy, data, laboratory, and operational infrastructure needed to responsibly translate peptide programs into patient-facing studies and services. Both companies expect to remain in stealth through Q1 2027.

CSBio is a peptide contract manufacturing founded in 1993. CSBio initial products were a complete line of automated synthesizers for manufacturing and process development, with a focus on cGMP production. In 1994, CSBio opened a custom peptide facility and began producing high quality compounds for research organizations and pharmaceutical companies worldwide. In 2004, CSBio opened a peptide production facility in Menlo Park, CA and in 2014, CSBio expanded production capability through the addition of a new, state of the art building dedicated to cGMP peptide production. In 2017, CSBio passed a FDA inspection and were recommended to be approved for commercial drug substance manufacturing. In 2023, additional cGMP clinical production capacity was added in Milpitas, CA.

Yowei Therapeutics is seeking a California Registered Nurse to support protocol-driven clinical research and longevity programs under appropriate medical, protocol, and site oversight.

Job Duties:

• Conduct protocol- and scope-authorized participant assessments, visits, education, vital signs, medication reconciliation, specimen collection, and clinical procedures.
• Administer medications or investigational products only when authorized by applicable law, protocol, orders, delegation, training, and site procedures.
• Review visit readiness, orders, eligibility documentation, supplies, product availability, emergency equipment, and required source documents.
• Identify and promptly escalate adverse events, safety concerns, protocol deviations, abnormal findings, and participant questions to the appropriate qualified clinician or study owner.
• Maintain accurate, timely source documentation and required entries in approved clinical and operational systems.
• Coordinate with investigators, NPs, CRCs, pharmacy, laboratories, imaging providers, sponsors, and participants.
• Support informed-consent discussions without replacing the investigator’s responsibilities and verify required consent documentation before procedures.
• Maintain training, competency, licensure, certifications, privacy, infection-control, and emergency-readiness requirements.
• Support visit scheduling, follow-up, data-query resolution, supply accountability, and inspection readiness.

• Active, unrestricted California RN license.
• Current BLS certification; ACLS or other certifications as required by the final procedures and site model.
• 3+ years of clinical nursing experience in research, infusion, ambulatory care, oncology, endocrinology, wellness, or another relevant setting.
• Strong assessment, documentation, participant communication, and escalation skills.
• Ability to work within protocol, licensure, delegation, privacy, and medical-governance boundaries.

• Medical, dental, and vision insurance (Kaiser HMO or BlueShield PPO. Employer pays 85% for Employee and 50% for Employee’s family; Dental: Aetna Dental, Delta Dental, Guardian Dental, MetLife Dental. Vision: VSP and Aetna EyeMed)
• Basic life ($20,000 paid by company) and supplemental life insurance (optional supplemental).
• Disability insurance 50% standard employer paid.
• 401k 10% 1:1 match
• PTO policy. 10 days PTO
• Companywide paid holiday during: Week of July 4, Thanksgiving (2 days), Week of December 25
• Carpool, clean air vehicle, and cell phone reimbursement
• Employee rewards and recognition program
• Company organized social events
• Quarterly sponsored team building activities